SciELO - Scientific Electronic Library Online

vol.14 issue2Determination of the chemical composition, amino acid levels and energy values of different poultry offal meals for broilersSafety and efficacy of a salmonella gallinarum ΔcobSΔcbiA strain with potential to prevent chicken infections by salmonella gallinarum and salmonella enteritidis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Brazilian Journal of Poultry Science

Print version ISSN 1516-635X


NASEEM, S et al. Immunomodulatory and growth-promoting effect of a probiotic supplemented in the feed of broiler chicks vaccinated against infectious bursal disease. Rev. Bras. Cienc. Avic. [online]. 2012, vol.14, n.2, pp.109-113. ISSN 1516-635X.

This study was designed to investigate the effects of a probiotic plus an immunomodulatory product on the growth performance, immune response and net economic returns of broiler chicks vaccinated against Infectious bursal diseases virus (IBDV). A flock of 350 day-old chicks were equally and randomly distributed in seven groups, each comprising 50 birds. A mixture of microorganisms (1Probiotic) or Cyclophosphamide (immune suppressor) was offered through feed supplementation to different groups. The Probiotic, consisting of Lactobacillus species, Bifidobacterium, Streptococcus salivarius and Enterococcus faecium, in addition to Aspergillus oryza and Candida pintolopessii. Compared with control treatment group, the probiotic-supplemented chicks had better feed conversion ratio (FCR) (1.938 and 1.959), with significantly heavier live body weight 2141.0±34.2 and 2120.3±33.2, respectively. Similarly, their antibody titers against IBDV were significantly higher (941 and 832) on day 35. No morbidity and mortality were observed in these groups. This study suggests that a product composed of a probiotic and cyclophosphamide enhanced the growth rate as well as the immunity against infectious bursal disease virus of broilers chicks.

Keywords : Probiotic; Cyclophosphamide; Mortality; Morbidity; IBDV.

        · text in English     · English ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License